Skip to main content
. 2021 Jan 13;9(1):45. doi: 10.3390/vaccines9010045

Figure 1.

Figure 1

Characterization and intracellular localization of the E2-ferritin and ferritin nanoplatform. (a) Schematic representation of the ferritin (above) and E2-ferritin (below) nanoplatform expression cassette. (b) Immunofluorescence assay (IFA) for nanocage intracellular location using anti-His tag antibody (left) and anti-CSFV E2 mAb (right) as primary antibodies followed by Alexa Fluor 555 as secondary antibody using confocal microscopy. (c) Protein expression detected by Western blotting using anti-His tag monoclonal antibody.